In humans, Tra2β expression levels change in several cancers (reviewed by Best et al. 19), and Tra2β is implicated in the pathology of other diseases including spinal muscular atrophy20, Alzheimer’s disease21 and frontotemporal dementia and Parkinsonism linked to chromosome 17 (ref. 22). Here, TRA2B is linked to frontotemporal dementia.